MedTrace Logo

Rescue Quadratus Lumborum Blocks for Post-cesarean Pain

NCT04397458 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2023-11-03

No results posted yet for this study

Summary

The purpose of this study is to assess whether quadratus lumborum (QL) block performed 1 day after cesarean delivery will provide supplemental post-cesarean analgesia and reduce opioid requirements.

Conditions

  • Morphine
  • Analgesics
  • Analgesics, Opioid
  • Peripheral Nervous System Agents

Interventions

DRUG

Saline

0.9% saline on each side

DRUG

Bupivacaine

0.25% bupivacaine (50mg) on each side

DRUG

Dexamethasone

3mg preservative-free dexamethasone on each side

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Linden Lee, MD · The University of Texas Health Science Center, Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-06-30
Completion
2022-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04397458 on ClinicalTrials.gov